About Us
Contact Us
Regulatory
Community
Site Map
Links
Stock Price
Glossary
Investor Relations
Media Gateway
Businesses
Governance
Uranium 101
Careers
Company Profile Why Invest? Events Calendar Management Views Financial Reporting Shareholder Information
Q3
Down Arrow
Q2
Q1
Contact IR
 
TSX:  $19.75 (-2.49)
NYSE:  $18.00 (-2.48)
  15 minute delay
Uranium Price
Print Page
Print Page

Cash Statement

Cameco Corporation
Consolidated Statements of Cash Flow

(Unaudited)
(In Thousands)

    Three Months Ended Nine Months Ended
    Sept 30/99 Sept 30/98 Sept 30/99 Sept 30/98

Operating activities                
  Net earnings $31,977    $18,215    $60,216    $55,384   
  Items not requiring (providing) cash:                
     Depreciation, depletion and reclamation 31,148    34,959    91,457    88,895   
     Provision for deferred taxes (57,578)   12,485    (32,588)   33,623   
     Writedown of mineral properties 45,523      45,523     
     Other non-cash items 3,545      3,545     
     Gain on sale of assets (11,606)     (11,606)    
     Deferred revenue recognized (3,386)   (3,220)   (9,193)   (12,413)  
  Other operating items 61,278    (77,248)   22,471    (99,016)  

Cash provided by (used in) operations 100,901    (14,809)   169,825    66,473   

                   
Investing activities                
  Additions to property, plant and equipment (66,736)   (57,930)   (174,753)   (122,759)  
  Change in long-term receivables, investments and other   (824)     4,108   
  Sale of net business assets 238,053      238,053     
  Acquisition of net business assets   (489,522)     (489,522)  
  Proceeds on sale of property, plant and equipment 852    345    1,261    2,404   

Cash provided by (used in) investing 172,169    (547,931)   64,561    (605,769)  

                   
Financing activities                
  Increase in debt 100,000    491,709    100,000    642,311   
  Repayment of debt (348,244)     (308,316)   (143,650)  
  Issue of shares 402    369    1,781    2,507   
  Preferred securities charges (2,235)     (6,717)    
  Dividends (7,213)   (7,201)   (21,629)   (21,575)  

Cash provided by (used in) financing (257,290)   484,877    (234,881)   479,593   

                   
  Increase (decrease) in cash during the period 15,780    (77,863)   (495)   (59,703)  
  Cash at beginning of period 20,191    127,882    36,466    109,722   

Cash at end of period $35,971    $50,019    $35,971   $50,019   

See accompanying notes to consolidated financial statements.